Thapaliya, Kiran, Marshall-Gradisnik, Sonya, Staines, Donald et al. · The European journal of neuroscience · 2021 · DOI
Quick Summary
This study used a specialized brain imaging technique called diffusion tensor imaging (DTI) to look for structural changes in the brains of ME/CFS patients compared to healthy people. The researchers found subtle differences in how water moves through certain nerve fiber pathways in the brains of patients who met strict diagnostic criteria for ME/CFS, particularly in areas controlling movement, coordination, and breathing. These brain changes were linked to patient symptoms like difficulty processing information, fatigue, and sleep problems.
Why It Matters
This study provides objective neuroimaging evidence that ME/CFS involves measurable physical changes in brain structure, helping validate that the condition is biological rather than purely psychological. The identification of DTI as a potential biomarker could eventually improve diagnosis and help researchers understand what goes wrong in ME/CFS brains. These findings support the need for strict diagnostic criteria in future research to ensure studies examine the same patient population.
Observed Findings
Decreased axial and mean diffusivity in descending cortico-cerebellar tracts of the midbrain and pons in ME/CFS_ICC patients versus controls
Increased transverse diffusivity in the medulla in ME/CFS_ICC patients
Decreased mode of anisotropy in the superior longitudinal fasciculus region in ME/CFS_ICC patients
Abnormal correlations between DTI parameters and clinical measures (information processing score, SF-36 physical function, sleep disturbance, respiration rate) in grey and white matter regions
No significant DTI abnormalities detected in ME/CFS_Fukuda group versus controls
Inferred Conclusions
DTI parameters are sensitive to microstructural brain changes in ME/CFS and could serve as an objective imaging biomarker of disease pathophysiology
Strict diagnostic criteria (ICC) are essential for identifying ME/CFS-related neurological abnormalities in research studies
Microstructural changes in brain regions controlling motor function, coordination, and autonomic regulation correlate with clinical symptom severity in ME/CFS
The International Consensus Criteria may better identify a homogeneous ME/CFS population with consistent neuropathological features than the Fukuda criteria
Remaining Questions
What This Study Does Not Prove
This study does not prove that the observed brain changes *cause* ME/CFS symptoms—only that they are associated with the condition. The cross-sectional design cannot determine whether these microstructural changes develop before, during, or after symptom onset. The study cannot explain the biological mechanisms behind these changes, and findings apply specifically to patients meeting ICC criteria, not necessarily all individuals with ME/CFS-like symptoms.
What is the longitudinal trajectory of these DTI changes over time, and do they correlate with symptom progression or remission?
What are the underlying biological mechanisms causing these microstructural white matter abnormalities in ME/CFS?
Can these DTI parameters effectively differentiate ME/CFS from other conditions causing similar symptoms, and what is their diagnostic sensitivity and specificity?
Do these brain changes reflect primary neurological pathology, secondary effects of systemic illness, or consequences of deconditioning and reduced activity?